nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritonavir—ABCB1—peripheral nervous system neoplasm	0.191	1	CbGaD
Ritonavir—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0355	0.0592	CbGbCtD
Ritonavir—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0342	0.0571	CbGbCtD
Ritonavir—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0257	0.0428	CbGbCtD
Ritonavir—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0237	0.0396	CbGbCtD
Ritonavir—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0235	0.0392	CbGbCtD
Ritonavir—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0235	0.0392	CbGbCtD
Ritonavir—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0224	0.0373	CbGbCtD
Ritonavir—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0218	0.0364	CbGbCtD
Ritonavir—ABCC1—Etoposide—peripheral nervous system neoplasm	0.02	0.0334	CbGbCtD
Ritonavir—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0195	0.0326	CbGbCtD
Ritonavir—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0176	0.0294	CbGbCtD
Ritonavir—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.017	0.0283	CbGbCtD
Ritonavir—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0162	0.027	CbGbCtD
Ritonavir—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0151	0.0251	CbGbCtD
Ritonavir—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0148	0.0247	CbGbCtD
Ritonavir—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0146	0.0244	CbGbCtD
Ritonavir—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0141	0.0236	CbGbCtD
Ritonavir—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0137	0.0228	CbGbCtD
Ritonavir—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0136	0.0227	CbGbCtD
Ritonavir—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0134	0.0223	CbGbCtD
Ritonavir—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0123	0.0206	CbGbCtD
Ritonavir—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0123	0.0206	CbGbCtD
Ritonavir—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0118	0.0197	CbGbCtD
Ritonavir—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0113	0.0188	CbGbCtD
Ritonavir—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0108	0.018	CbGbCtD
Ritonavir—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0108	0.018	CbGbCtD
Ritonavir—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0101	0.0169	CbGbCtD
Ritonavir—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.00959	0.016	CbGbCtD
Ritonavir—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.00955	0.0159	CbGbCtD
Ritonavir—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00914	0.0152	CbGbCtD
Ritonavir—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00856	0.0143	CbGbCtD
Ritonavir—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0081	0.0135	CbGbCtD
Ritonavir—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00742	0.0124	CbGbCtD
Ritonavir—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0074	0.0123	CbGbCtD
Ritonavir—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00714	0.0119	CbGbCtD
Ritonavir—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00688	0.0115	CbGbCtD
Ritonavir—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.00643	0.0107	CbGbCtD
Ritonavir—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00552	0.00921	CbGbCtD
Ritonavir—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00527	0.00879	CbGbCtD
Ritonavir—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00507	0.00845	CbGbCtD
Ritonavir—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00492	0.0082	CbGbCtD
Ritonavir—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00483	0.00806	CbGbCtD
Ritonavir—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00329	0.00549	CbGbCtD
Ritonavir—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00316	0.00527	CbGbCtD
Ritonavir—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0031	0.00518	CbGbCtD
Ritonavir—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00289	0.00483	CbGbCtD
Ritonavir—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00197	0.00329	CbGbCtD
Ritonavir—Atazanavir—ABCB1—peripheral nervous system neoplasm	0.00097	0.387	CrCbGaD
Ritonavir—Carfilzomib—ABCB1—peripheral nervous system neoplasm	0.000848	0.338	CrCbGaD
Ritonavir—Lopinavir—ABCB1—peripheral nervous system neoplasm	0.000691	0.275	CrCbGaD
Ritonavir—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	5.44e-05	0.000263	CcSEcCtD
Ritonavir—Paraesthesia—Etoposide—peripheral nervous system neoplasm	5.43e-05	0.000263	CcSEcCtD
Ritonavir—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000262	CcSEcCtD
Ritonavir—Weight decreased—Epirubicin—peripheral nervous system neoplasm	5.39e-05	0.000261	CcSEcCtD
Ritonavir—Dyspnoea—Etoposide—peripheral nervous system neoplasm	5.39e-05	0.000261	CcSEcCtD
Ritonavir—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	5.37e-05	0.00026	CcSEcCtD
Ritonavir—Somnolence—Etoposide—peripheral nervous system neoplasm	5.37e-05	0.00026	CcSEcCtD
Ritonavir—Asthenia—Vincristine—peripheral nervous system neoplasm	5.35e-05	0.000259	CcSEcCtD
Ritonavir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	5.31e-05	0.000257	CcSEcCtD
Ritonavir—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	5.3e-05	0.000257	CcSEcCtD
Ritonavir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	5.3e-05	0.000256	CcSEcCtD
Ritonavir—Rash—Dactinomycin—peripheral nervous system neoplasm	5.26e-05	0.000255	CcSEcCtD
Ritonavir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	5.25e-05	0.000254	CcSEcCtD
Ritonavir—Renal failure—Epirubicin—peripheral nervous system neoplasm	5.22e-05	0.000253	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	5.22e-05	0.000253	CcSEcCtD
Ritonavir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	5.21e-05	0.000252	CcSEcCtD
Ritonavir—Fatigue—Etoposide—peripheral nervous system neoplasm	5.21e-05	0.000252	CcSEcCtD
Ritonavir—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	5.21e-05	0.000252	CcSEcCtD
Ritonavir—Stomatitis—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000251	CcSEcCtD
Ritonavir—Jaundice—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000251	CcSEcCtD
Ritonavir—Constipation—Etoposide—peripheral nervous system neoplasm	5.17e-05	0.00025	CcSEcCtD
Ritonavir—Pain—Etoposide—peripheral nervous system neoplasm	5.17e-05	0.00025	CcSEcCtD
Ritonavir—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.00025	CcSEcCtD
Ritonavir—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.00025	CcSEcCtD
Ritonavir—Dysuria—Doxorubicin—peripheral nervous system neoplasm	5.15e-05	0.00025	CcSEcCtD
Ritonavir—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	5.15e-05	0.00025	CcSEcCtD
Ritonavir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	5.12e-05	0.000248	CcSEcCtD
Ritonavir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	5.1e-05	0.000247	CcSEcCtD
Ritonavir—Sweating—Epirubicin—peripheral nervous system neoplasm	5.09e-05	0.000247	CcSEcCtD
Ritonavir—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000247	CcSEcCtD
Ritonavir—Haematuria—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.000245	CcSEcCtD
Ritonavir—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000244	CcSEcCtD
Ritonavir—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.000243	CcSEcCtD
Ritonavir—Epistaxis—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000243	CcSEcCtD
Ritonavir—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	4.99e-05	0.000241	CcSEcCtD
Ritonavir—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000241	CcSEcCtD
Ritonavir—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.98e-05	0.000241	CcSEcCtD
Ritonavir—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000241	CcSEcCtD
Ritonavir—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.96e-05	0.00024	CcSEcCtD
Ritonavir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.94e-05	0.000239	CcSEcCtD
Ritonavir—Dizziness—Vincristine—peripheral nervous system neoplasm	4.93e-05	0.000239	CcSEcCtD
Ritonavir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.92e-05	0.000238	CcSEcCtD
Ritonavir—Rash—Alitretinoin—peripheral nervous system neoplasm	4.88e-05	0.000236	CcSEcCtD
Ritonavir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.88e-05	0.000236	CcSEcCtD
Ritonavir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.86e-05	0.000235	CcSEcCtD
Ritonavir—Headache—Alitretinoin—peripheral nervous system neoplasm	4.85e-05	0.000235	CcSEcCtD
Ritonavir—Renal failure—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000234	CcSEcCtD
Ritonavir—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000233	CcSEcCtD
Ritonavir—Urticaria—Etoposide—peripheral nervous system neoplasm	4.8e-05	0.000232	CcSEcCtD
Ritonavir—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000232	CcSEcCtD
Ritonavir—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000232	CcSEcCtD
Ritonavir—Jaundice—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000232	CcSEcCtD
Ritonavir—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.78e-05	0.000231	CcSEcCtD
Ritonavir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.78e-05	0.000231	CcSEcCtD
Ritonavir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.78e-05	0.000231	CcSEcCtD
Ritonavir—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000231	CcSEcCtD
Ritonavir—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000231	CcSEcCtD
Ritonavir—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000231	CcSEcCtD
Ritonavir—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000231	CcSEcCtD
Ritonavir—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.00023	CcSEcCtD
Ritonavir—Vomiting—Vincristine—peripheral nervous system neoplasm	4.74e-05	0.00023	CcSEcCtD
Ritonavir—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.73e-05	0.000229	CcSEcCtD
Ritonavir—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000229	CcSEcCtD
Ritonavir—Sweating—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000228	CcSEcCtD
Ritonavir—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000228	CcSEcCtD
Ritonavir—Rash—Vincristine—peripheral nervous system neoplasm	4.7e-05	0.000228	CcSEcCtD
Ritonavir—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.7e-05	0.000228	CcSEcCtD
Ritonavir—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000227	CcSEcCtD
Ritonavir—Haematuria—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000227	CcSEcCtD
Ritonavir—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	4.69e-05	0.000227	CcSEcCtD
Ritonavir—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000226	CcSEcCtD
Ritonavir—Headache—Vincristine—peripheral nervous system neoplasm	4.67e-05	0.000226	CcSEcCtD
Ritonavir—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000225	CcSEcCtD
Ritonavir—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000224	CcSEcCtD
Ritonavir—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000223	CcSEcCtD
Ritonavir—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.6e-05	0.000223	CcSEcCtD
Ritonavir—Visual impairment—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.000222	CcSEcCtD
Ritonavir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.51e-05	0.000219	CcSEcCtD
Ritonavir—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000218	CcSEcCtD
Ritonavir—Eye disorder—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000216	CcSEcCtD
Ritonavir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.45e-05	0.000216	CcSEcCtD
Ritonavir—Tinnitus—Epirubicin—peripheral nervous system neoplasm	4.45e-05	0.000215	CcSEcCtD
Ritonavir—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000215	CcSEcCtD
Ritonavir—Nausea—Vincristine—peripheral nervous system neoplasm	4.43e-05	0.000215	CcSEcCtD
Ritonavir—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000214	CcSEcCtD
Ritonavir—Flushing—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000214	CcSEcCtD
Ritonavir—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000214	CcSEcCtD
Ritonavir—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000214	CcSEcCtD
Ritonavir—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000214	CcSEcCtD
Ritonavir—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000213	CcSEcCtD
Ritonavir—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000212	CcSEcCtD
Ritonavir—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000211	CcSEcCtD
Ritonavir—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.00021	CcSEcCtD
Ritonavir—Asthenia—Etoposide—peripheral nervous system neoplasm	4.34e-05	0.00021	CcSEcCtD
Ritonavir—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	4.34e-05	0.00021	CcSEcCtD
Ritonavir—Angiopathy—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000209	CcSEcCtD
Ritonavir—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000209	CcSEcCtD
Ritonavir—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000209	CcSEcCtD
Ritonavir—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000208	CcSEcCtD
Ritonavir—Chills—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000207	CcSEcCtD
Ritonavir—Pruritus—Etoposide—peripheral nervous system neoplasm	4.28e-05	0.000207	CcSEcCtD
Ritonavir—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000206	CcSEcCtD
Ritonavir—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.19e-05	0.000203	CcSEcCtD
Ritonavir—Mental disorder—Epirubicin—peripheral nervous system neoplasm	4.18e-05	0.000202	CcSEcCtD
Ritonavir—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000202	CcSEcCtD
Ritonavir—Rash—Cisplatin—peripheral nervous system neoplasm	4.16e-05	0.000201	CcSEcCtD
Ritonavir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.16e-05	0.000201	CcSEcCtD
Ritonavir—Malnutrition—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000201	CcSEcCtD
Ritonavir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.13e-05	0.0002	CcSEcCtD
Ritonavir—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	4.12e-05	0.0002	CcSEcCtD
Ritonavir—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.000199	CcSEcCtD
Ritonavir—Flushing—Doxorubicin—peripheral nervous system neoplasm	4.09e-05	0.000198	CcSEcCtD
Ritonavir—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	4.09e-05	0.000198	CcSEcCtD
Ritonavir—Flatulence—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.000198	CcSEcCtD
Ritonavir—Tension—Epirubicin—peripheral nervous system neoplasm	4.07e-05	0.000197	CcSEcCtD
Ritonavir—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000197	CcSEcCtD
Ritonavir—Nervousness—Epirubicin—peripheral nervous system neoplasm	4.03e-05	0.000195	CcSEcCtD
Ritonavir—Back pain—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000194	CcSEcCtD
Ritonavir—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000194	CcSEcCtD
Ritonavir—Dizziness—Etoposide—peripheral nervous system neoplasm	4e-05	0.000193	CcSEcCtD
Ritonavir—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000193	CcSEcCtD
Ritonavir—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000193	CcSEcCtD
Ritonavir—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000192	CcSEcCtD
Ritonavir—Chills—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000192	CcSEcCtD
Ritonavir—Nausea—Cisplatin—peripheral nervous system neoplasm	3.92e-05	0.00019	CcSEcCtD
Ritonavir—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.91e-05	0.000189	CcSEcCtD
Ritonavir—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000187	CcSEcCtD
Ritonavir—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.85e-05	0.000186	CcSEcCtD
Ritonavir—Vomiting—Etoposide—peripheral nervous system neoplasm	3.84e-05	0.000186	CcSEcCtD
Ritonavir—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000186	CcSEcCtD
Ritonavir—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.84e-05	0.000186	CcSEcCtD
Ritonavir—Agitation—Epirubicin—peripheral nervous system neoplasm	3.81e-05	0.000185	CcSEcCtD
Ritonavir—Rash—Etoposide—peripheral nervous system neoplasm	3.81e-05	0.000184	CcSEcCtD
Ritonavir—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.81e-05	0.000184	CcSEcCtD
Ritonavir—Headache—Etoposide—peripheral nervous system neoplasm	3.79e-05	0.000183	CcSEcCtD
Ritonavir—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000183	CcSEcCtD
Ritonavir—Tension—Doxorubicin—peripheral nervous system neoplasm	3.77e-05	0.000182	CcSEcCtD
Ritonavir—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000182	CcSEcCtD
Ritonavir—Malaise—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.000181	CcSEcCtD
Ritonavir—Nervousness—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000181	CcSEcCtD
Ritonavir—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000181	CcSEcCtD
Ritonavir—Syncope—Epirubicin—peripheral nervous system neoplasm	3.72e-05	0.00018	CcSEcCtD
Ritonavir—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.72e-05	0.00018	CcSEcCtD
Ritonavir—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.00018	CcSEcCtD
Ritonavir—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000179	CcSEcCtD
Ritonavir—Palpitations—Epirubicin—peripheral nervous system neoplasm	3.67e-05	0.000178	CcSEcCtD
Ritonavir—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.65e-05	0.000177	CcSEcCtD
Ritonavir—Cough—Epirubicin—peripheral nervous system neoplasm	3.62e-05	0.000175	CcSEcCtD
Ritonavir—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.62e-05	0.000175	CcSEcCtD
Ritonavir—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000174	CcSEcCtD
Ritonavir—Nausea—Etoposide—peripheral nervous system neoplasm	3.59e-05	0.000174	CcSEcCtD
Ritonavir—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000173	CcSEcCtD
Ritonavir—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.56e-05	0.000173	CcSEcCtD
Ritonavir—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.55e-05	0.000172	CcSEcCtD
Ritonavir—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.53e-05	0.000171	CcSEcCtD
Ritonavir—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.53e-05	0.000171	CcSEcCtD
Ritonavir—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.53e-05	0.000171	CcSEcCtD
Ritonavir—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.53e-05	0.000171	CcSEcCtD
Ritonavir—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.52e-05	0.00017	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.51e-05	0.00017	CcSEcCtD
Ritonavir—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000169	CcSEcCtD
Ritonavir—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.000168	CcSEcCtD
Ritonavir—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.46e-05	0.000167	CcSEcCtD
Ritonavir—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000167	CcSEcCtD
Ritonavir—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.000167	CcSEcCtD
Ritonavir—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.000166	CcSEcCtD
Ritonavir—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.42e-05	0.000165	CcSEcCtD
Ritonavir—Palpitations—Doxorubicin—peripheral nervous system neoplasm	3.39e-05	0.000164	CcSEcCtD
Ritonavir—Oedema—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000164	CcSEcCtD
Ritonavir—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000163	CcSEcCtD
Ritonavir—Cough—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.000162	CcSEcCtD
Ritonavir—Shock—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000161	CcSEcCtD
Ritonavir—Convulsion—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000161	CcSEcCtD
Ritonavir—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.32e-05	0.000161	CcSEcCtD
Ritonavir—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.32e-05	0.000161	CcSEcCtD
Ritonavir—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	0.000161	CcSEcCtD
Ritonavir—Tachycardia—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.00016	CcSEcCtD
Ritonavir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000159	CcSEcCtD
Ritonavir—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000159	CcSEcCtD
Ritonavir—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	3.27e-05	0.000158	CcSEcCtD
Ritonavir—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.27e-05	0.000158	CcSEcCtD
Ritonavir—Chest pain—Doxorubicin—peripheral nervous system neoplasm	3.27e-05	0.000158	CcSEcCtD
Ritonavir—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.000158	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.25e-05	0.000157	CcSEcCtD
Ritonavir—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000156	CcSEcCtD
Ritonavir—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.23e-05	0.000156	CcSEcCtD
Ritonavir—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	3.2e-05	0.000155	CcSEcCtD
Ritonavir—Hypotension—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000153	CcSEcCtD
Ritonavir—Confusional state—Doxorubicin—peripheral nervous system neoplasm	3.16e-05	0.000153	CcSEcCtD
Ritonavir—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000152	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.09e-05	0.000149	CcSEcCtD
Ritonavir—Shock—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000149	CcSEcCtD
Ritonavir—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000149	CcSEcCtD
Ritonavir—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000149	CcSEcCtD
Ritonavir—Insomnia—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000148	CcSEcCtD
Ritonavir—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	3.06e-05	0.000148	CcSEcCtD
Ritonavir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	3.04e-05	0.000147	CcSEcCtD
Ritonavir—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	3.04e-05	0.000147	CcSEcCtD
Ritonavir—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000147	CcSEcCtD
Ritonavir—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	3.02e-05	0.000146	CcSEcCtD
Ritonavir—Somnolence—Epirubicin—peripheral nervous system neoplasm	3.01e-05	0.000146	CcSEcCtD
Ritonavir—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.99e-05	0.000145	CcSEcCtD
Ritonavir—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000144	CcSEcCtD
Ritonavir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.94e-05	0.000143	CcSEcCtD
Ritonavir—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000142	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.000142	CcSEcCtD
Ritonavir—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.000141	CcSEcCtD
Ritonavir—Pain—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.00014	CcSEcCtD
Ritonavir—Constipation—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.00014	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.86e-05	0.000138	CcSEcCtD
Ritonavir—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000137	CcSEcCtD
Ritonavir—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.81e-05	0.000136	CcSEcCtD
Ritonavir—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.79e-05	0.000135	CcSEcCtD
Ritonavir—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.79e-05	0.000135	CcSEcCtD
Ritonavir—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.79e-05	0.000135	CcSEcCtD
Ritonavir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.77e-05	0.000134	CcSEcCtD
Ritonavir—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000134	CcSEcCtD
Ritonavir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000132	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	0.000131	CcSEcCtD
Ritonavir—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.000131	CcSEcCtD
Ritonavir—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.69e-05	0.00013	CcSEcCtD
Ritonavir—Pain—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.00013	CcSEcCtD
Ritonavir—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.00013	CcSEcCtD
Ritonavir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.68e-05	0.00013	CcSEcCtD
Ritonavir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.68e-05	0.00013	CcSEcCtD
Ritonavir—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	0.000125	CcSEcCtD
Ritonavir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.56e-05	0.000124	CcSEcCtD
Ritonavir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.5e-05	0.000121	CcSEcCtD
Ritonavir—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.49e-05	0.000121	CcSEcCtD
Ritonavir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.48e-05	0.00012	CcSEcCtD
Ritonavir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.48e-05	0.00012	CcSEcCtD
Ritonavir—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.43e-05	0.000118	CcSEcCtD
Ritonavir—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.4e-05	0.000116	CcSEcCtD
Ritonavir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.32e-05	0.000112	CcSEcCtD
Ritonavir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.31e-05	0.000112	CcSEcCtD
Ritonavir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.25e-05	0.000109	CcSEcCtD
Ritonavir—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.24e-05	0.000108	CcSEcCtD
Ritonavir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.22e-05	0.000107	CcSEcCtD
Ritonavir—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.15e-05	0.000104	CcSEcCtD
Ritonavir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	0.000104	CcSEcCtD
Ritonavir—Rash—Epirubicin—peripheral nervous system neoplasm	2.14e-05	0.000103	CcSEcCtD
Ritonavir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.13e-05	0.000103	CcSEcCtD
Ritonavir—Headache—Epirubicin—peripheral nervous system neoplasm	2.12e-05	0.000103	CcSEcCtD
Ritonavir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.07e-05	0.0001	CcSEcCtD
Ritonavir—Nausea—Epirubicin—peripheral nervous system neoplasm	2.01e-05	9.74e-05	CcSEcCtD
Ritonavir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.99e-05	9.65e-05	CcSEcCtD
Ritonavir—Rash—Doxorubicin—peripheral nervous system neoplasm	1.98e-05	9.57e-05	CcSEcCtD
Ritonavir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.97e-05	9.56e-05	CcSEcCtD
Ritonavir—Headache—Doxorubicin—peripheral nervous system neoplasm	1.96e-05	9.51e-05	CcSEcCtD
Ritonavir—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.86e-05	9.01e-05	CcSEcCtD
